STAT

SEPTEMBER 10, 2024

Amid calls to expand access to medicines in low- and middle-income countries, a new analysis finds that most of the world’s 20 largest pharmaceutical companies have taken steps to reach patients, but many efforts are yielding decidedly mixed results. On the one hand, 19 companies have established methods for providing treatments to these countries — but only nine of the drugmakers created comprehensive plans.

Pharmaceutical Companies 326

Pharmaceutical Companies Pharmaceutical Companies 326

PharmaVoice

SEPTEMBER 10, 2024

Over the past 10 years, PD1-blocking medicines have transformed cancer care. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Pharmaceutical Companies 245

Pharmaceutical Companies Pharmaceutical Companies 245

STAT

SEPTEMBER 10, 2024

The first late-stage trial of a GLP-1 drug in young children with obesity showed the treatment helped lower body mass index. But the findings also raise questions about whether obesity medications, some of which are currently approved for teenagers, should also be given to children at such a young age. The 56-week trial tested Novo Nordisk’s Saxenda, the predecessor of Wegovy, coupled with lifestyle interventions in children ages 6 to 12.

310

310

PharmaVoice

SEPTEMBER 10, 2024

Quality-adjusted life years are an important tool to frame a drug’s cost effectiveness, but they leave out other determinants of health.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

SEPTEMBER 10, 2024

Novo Nordisk on Tuesday reported that its new obesity pill that targets the amylin hormone led to substantial weight loss in an early study, boosting the company’s pipeline of next-generation candidates that may be more effective than Wegovy. In a Phase 1 trial, a 50-mg dose of the daily pill called amycretin, which activates receptors of both the amylin and GLP-1 hormones, led to 10.4% weight loss at about three months after the start of treatment.

Diabetes 323

Diabetes 323

Pharmaceutical Commerce

SEPTEMBER 10, 2024

A pooled analysis of the SWIFT-1 and SWIFT-2 trials found 54% reduction in exacerbation rates over 52 weeks in patients with severe asthma with type 2 inflammation treated with depemokimab.

105

105

Express Pharma

SEPTEMBER 10, 2024

As per GlobalData report, in August 2024, the healthcare sector experienced a notable decrease in deal value. The total deal value dropped by 29.6 per cent compared to August 2023. The industry reported 66 deals worth $7.5 billion, a significant decline from the average of 94 deals worth $18 billion in the previous 12-month period from August 2023 to July 2024.

103

103

STAT

SEPTEMBER 10, 2024

Two former Verily executives say that they are starting a new initiative, Highlander Health, to push forward an effort decades in the making: making it so that the records collected in hospitals can be used in real-time to advance science, decreasing the cost of conducting clinical trials and speeding medical progress while helping patients get the right drug for them.

Hospitals 279

Hospitals 279

Express Pharma

SEPTEMBER 10, 2024

Biogetica, known for its integrative approach to medicine, has reinforced its commitment to advancing evidence-based natural treatments in both the Indian and US markets. The company combines supplements, nutraceuticals, herbs, and homoeopathy to address health across all dimensions of human existence. Biogetica’s methods are founded on blending the strengths of different medical systems, ensuring that each product undergoes scientific validation.

Immunization 100

Immunization Immunity 100

STAT

SEPTEMBER 10, 2024

For months, investors have been asking Roivant Sciences chief executive Matt Gline to reveal the next drug it planned to buy with some of the $6 billion made from last year’s Roche deal. On Tuesday, Gline obliged. Roivant has acquired from Bayer, the German pharma company, an experimental drug called mosliciguat that will be developed as a treatment for certain types of pulmonary hypertension, a family of serious lung diseases in which high blood pressure affects the arteries in the lungs

276

276

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Pharmacist

SEPTEMBER 10, 2024

The General Pharmaceutical Council (GPhC) will release a consultation on changes to guidance for online pharmacies 'within the next couple of weeks', chief executive Duncan Rudkin has said. Proposed changes will emphasise the importance of a 'two-way dialogue between patients and prescriber', which may require further interaction beyond an asynchronous questionnaire, Mr Rudkin suggested.

Online Pharmacies 97

Online Pharmacies 97

STAT

SEPTEMBER 10, 2024

Seven years after the FDA approved Luxterna , scientists have yet to bring another congenital blindness treatment to the market. A team of researchers from the Perelman School of Medicine at the University of Pennsylvania aims to change this. The group recently published a study in The Lancet documenting their success using gene therapy to treat an inherited retinal blindness that affects as many as 100,000 people globally.

Documentation 272

Documentation 272

Express Pharma

SEPTEMBER 10, 2024

Detailed results from one of AstraZeneca’s key lung cancer trials released recently showed that its experimental precision drug did not significantly improve overall survival results for patients in the trial. The overall survival, or OS rates, in the TROPION-Lung01 trial “did not reach statistical significance”, the company said in a presentation at the World Conference on Lung Cancer in San Diego.

Chemotherapy 99

Chemotherapy 99

STAT

SEPTEMBER 10, 2024

What does it cost to have a baby in the United States? This question has always vexed me. I’ve tried unsuccessfully to prospectively price deliveries for family and friends over the years. After insurance, deliveries can range from a few hundred dollars to a couple of thousand. If you’re underinsured or have a more complex birth, it can cost more than $10,000 out of pocket.

Hospitals 262

Hospitals 262

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Express Pharma

SEPTEMBER 10, 2024

The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently dominated by Novo Nordisk and Eli Lilly, according to estimates from analysts at Morningstar and Pitchbook. In a joint report published on Monday, analysts estimated the market for obesity treatments could expand to $200 billion by 2031.

Diabetes 96

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Development 96

STAT

SEPTEMBER 10, 2024

Elevance Health, the parent of more than a dozen state Blue Cross Blue Shield plans, is purchasing Indiana University Health’s insurance business in a deal that would increase its dominance in several key cities in the state. IU Health’s decision to sell is the latest and most prominent example of hospital systems giving up on the idea that they can be both a provider and payer of care.

Health Insurance Companies 254

Health Insurance Companies Hospitals 254

pharmaphorum

SEPTEMBER 10, 2024

Investment in life sciences real estate is booming as the industry faces the looming 'patent cliff' Learn about the current trends and what lies ahead for this sector.

101

101

STAT

SEPTEMBER 10, 2024

This is Part 4 of “ Behind the Counter ,” an in-depth video series demystifying the complex world of patents and drug pricing. Years ago, when a brand-name medication’s patent expired, consumers had to wait a long time for a more affordable generic version to come to market. But in 1984, a little-known law put an end to that waiting period and paved the way for the large quantity of generic drugs available today.

Drug Pricing 256

Drug Pricing 256

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Outsourcing Pharma

SEPTEMBER 10, 2024

Creyon Bio Inc., a clinical-stage biotechnology company specializing in AI and machine learning-enabled oligonucleotide-based medicines (OBMs), recently announced the issuance of its second US patent.

94

94

STAT

SEPTEMBER 10, 2024

WASHINGTON – Powerful House lawmakers from both parties are skeptical of the Food and Drug Administration’s pitch to start collecting fees from e-cigarette companies, similar to how the agency assesses them on tobacco firms. FDA officials say that the fees, which e-cigarette companies would pay when filing applications with the agency, would give regulators resources to tackle the thousands of illegal vapes lining store shelves.

251

251

Drug Patent Watch

SEPTEMBER 10, 2024

The generic drug market has experienced significant growth over the past few decades, driven by the passage of the Hatch-Waxman Act in 1984 and subsequent legislation. Today, the market is more competitive than ever, with generic drugs accounting for over 90% of all prescriptions in the United States.

Drug Development 91

Drug Development 91

STAT

SEPTEMBER 10, 2024

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Flare Capital ‘s new examination of 4,000 healthcare AI venture capital deals looked at where investment has actually created value — that is, what early-stage, venture-backed technology matures enough to impact the health care ecosystem?

243

243

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

SEPTEMBER 10, 2024

Baltimore opted out of a national settlement last year, instead pursuing its own claim against the opioid manufacturer.

105

105

STAT

SEPTEMBER 10, 2024

Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with chronic spontaneous urticaria, an inflammatory skin disease, in a late-stage trial, the companies announced on Wednesday, bringing the firms closer to securing Food and Drug Administration approval after the agency rejected their application last year. In the Phase 3 trial, dubbed Liberty-Cupid Study C, patients took antihistamines, the current standard of care, and Dupixent or a placebo.

219

219

PioneerRx

SEPTEMBER 10, 2024

ER prescriptions requires a different kind urgency and attention to detail compared to maintenance medications — so let’s get on the right foot.

Prescription Management 96

Prescription Management 96

STAT

SEPTEMBER 10, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Hello, happy Tuesday. Temperatures are projected to be in the 50s every morning this week in Boston, per a glance at my phone. Is it officially fall? Where can I get a good apple cider donut? What stories should we report before the end of the year creeps up on us?

224

224

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Express Pharma

SEPTEMBER 10, 2024

The migraine market across the seven major markets (7MM*) is forecast to grow from $9.2 billion in 2023 to $16.4 billion by 2033 at a compound annual growth rate (CAGR) of 6.0 per cent, according to GlobalData. GlobalData’s latest report, “Migraine: Seven-Market Drug Forecast and Market Analysis,” reveals that primarily driven by increased prescription of calcitonin gene-related peptide (CGRP) antagonists—monoclonal antibodies (mAbs) for prevention and oral gepants for both acute and preventive

Compounding 88

Compounding 88

STAT

SEPTEMBER 10, 2024

Viridian Therapeutics said Tuesday that an experimental treatment improved the signs and symptoms of thyroid eye disease — results that achieved the primary goals of a Phase 3 clinical trial and compared favorably to a similar drug already approved and sold by Amgen.  In the 15-week study, 70% of participants responded to treatment with Viridian’s drug called VRDN-001, compared to 5% in the placebo group.

177

177

World Pharma News

SEPTEMBER 10, 2024

Bothnia dystrophy is a form of hereditary blindness, prevalent in the region Västerbotten in Sweden. A new study at Karolinska Institutet published in Nature Communications shows that gene therapy can improve vision in patients with the disease. Bothnia dystrophy occurs mainly in the region Västerbotten in Sweden, but the disease has also been identified in other parts of the world.

Communication 95

Communication 95

STAT

SEPTEMBER 10, 2024

Morning! Today, we’ll keep riding the bispecific wave, and tell you what Verily and FDA alum Amy Abernethy is up to next. Oh, and a programming note: The annual ESMO meeting opens this weekend, and we’ve got a pop-up newsletter. Sign up if you’re interested. The need-to-know this morning Roivant Sciences acquired from Bayer , the German pharma company, an experimental drug called mosliciguat that will be developed as a treatment for certain types of pulmonary hypertension, a

Drug Pricing 212

Drug Pricing Drug Development 212

The Pharmacist

SEPTEMBER 10, 2024

Community Pharmacy England (CPE) is concerned that local pharmacies may walk away from delivering Pharmacy First consultations if they cannot reach the thresholds for the £1,000 monthly payment. Speaking at the Avicenna Heathrow conference this weekend (8 September), CPE's director of NHS services Alastair Buxton said the number of clinical pathway consultations required for the […] The post CPE concerned pharmacies will 'walk away' from Pharmacy First appeared first on The Pharm

Community Pharmacies 83

Community Pharmacies 83